NorthCrest Asset Manangement’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Buy
+3,855
New +$233K 0.01% 669

Other funds holding CORT

NorthCrest Asset Manangement's CORT Position: Q2 2026 in Review

NorthCrest Asset Manangement opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 3,855 shares worth $359K. The stake represents 0.01% of the portfolio and ranks #669 among its holdings.

43 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • NorthCrest Asset Manangement held 3,855 shares of Corcept Therapeutics worth $359K as of Q2 2026.
  • Corcept Therapeutics was a new NorthCrest Asset Manangement position in Q2 2026.
  • Corcept Therapeutics made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #669 holding.
  • 43 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.